Literature DB >> 8121556

Isolated cerebral mucormycosis: case report and therapeutic considerations.

R Gollard1, C Rabb, R Larsen, P Chandrasoma.   

Abstract

Cerebral mucormycosis (without associated involvement of and invasion from the nasal sinuses and turbinates) is an extremely rare opportunistic infection of the central nervous system. We report the case of an intravenous drug abuser (who was negative for the human immunodeficiency virus) who presented with hemiparesis on the right side, slurred speech, altered mental status, and an unsteady gait. Imaging studies revealed a large left-side basal ganglia lesion. A stereotactic biopsy obtained a tissue sample that revealed wide, nonseptated hyphal fragments with granulomatous inflammation. The patient was treated with 3 gm of amphotericin B during a 5-month period. The patient had no residual neurological dysfunction after treatment. Open surgical resection was not employed. This case suggests that stereotactic biopsy followed by long-term amphotericin B therapy, in lieu of open surgical resection, represents a viable treatment option for this rare disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8121556     DOI: 10.1097/00006123-199401000-00026

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  A 28-year-old i.v. drug user with bilateral basal ganglia and brainstem lesions.

Authors:  Tanya P Lin; Rebecca Thompson; Bruce Coull
Journal:  Neurology       Date:  2013-02-12       Impact factor: 9.910

2.  Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user.

Authors:  R Blázquez; A Pinedo; J Cosín; P Miralles; C Lacruz; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

Review 3.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

4.  Isolated cerebral mucormycosis.

Authors:  Seong Rok Han; Chan Young Choi; Mee Joo; Choong Jin Whang
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

5.  Isolated cerebral mucormycosis of the basal ganglia.

Authors:  Athar N Malik; Wenya Linda Bi; Brett McCray; Malak Abedalthagafi; Henrikas Vaitkevicius; Ian F Dunn
Journal:  Clin Neurol Neurosurg       Date:  2014-06-23       Impact factor: 1.876

6.  Retrospective Clinical Study of Eighty-One Cases of Intracranial Mucormycosis.

Authors:  Jinjian Ma; Ruichao Jia; Jin Li; Yunyang Liu; Yuming Li; Peng Lin; Mingmu Zhang; Mu Li
Journal:  J Glob Infect Dis       Date:  2015 Oct-Dec

7.  Treatment of cerebral mucormycosis with drug therapy alone: A case report.

Authors:  Fatehi Elzein; Kiran Kalam; Nazik Mohammed; Ahmed Elzein; Fadhel Zaben Alotaibi; Mujtaba Khan; Abeer Albadani
Journal:  Med Mycol Case Rep       Date:  2018-10-28

8.  Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature.

Authors:  Eric A Meyerowitz; Sarimer Sanchez; Michael K Mansour; Virginia A Triant; Marcia B Goldberg
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.